MedStar Heart & Vascular Institute physicians participating in a clinical trial have become the first in the Mid-Atlantic region to implant the Watchman FLX device. The Watchman FLX is the next generation of a potentially life-changing device proven to reduce the risk of stroke in certain patients with atrial fibrillation (AFib).

Northwestern Medicine Bluhm Cardiovascular Institute in Illinois received a $25 million gift from the Bluhm Family Charitable Foundation, formed by Neil G. Bluhm, a prominent Chicago philanthropist and real estate developer. The gift will fund, in part, a first-of-its-kind center that utilizes artificial intelligence (AI) and machine learning to advance the study and treatment of cardiovascular disease.Northwestern Medicine Bluhm Cardiovascular Institute in Illinois received a $25 million gift from the Bluhm Family Charitable Foundation, formed by Neil G. Bluhm, a prominent Chicago philanthropist and real estate developer. The gift will fund, in part, a first-of-its-kind center that utilizes artificial intelligence (AI) and machine learning to advance the study and treatment of cardiovascular disease.

New research finds changes in cellular struts called microtubules (MT) can affect the stiffness of diseased human heart muscle cells. Furthermore, reversing these modifications can lessen the stiffness and improve the beating strength of these cells isolated from transplant patients with heart failure, found researchers from the Perelman School of Medicine at the University of Pennsylvania. This Nature Medicine new study is a continuation of research conducted two years ago on how MTs are involved in regulating the heartbeat.

Digisonics will exhibit its latest functionality for data-driven decisions at the American Society of Echocardiography 29th Annual Scientific Sessions, June 22-26 in Nashville, Tenn.

5th European Endovascular and Interventional Cardiology Conference

Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-mortem diagnosis, according to a study appearing online in the journal Radiology. Researchers said the findings could have important implications for criminal investigations and hospital quality control efforts.


More than 60 companies and organizations are displaying their latest products and services at the 2018 American Society of Echocardiography (ASE) 29th Annual Scientific Sessions, planned for June 22-26, 2018 at the Gaylord Opryland Resort and Convention Center in Nashville, Tenn. ASE 2018 is the world’s premier meeting for cardiovascular ultrasound practitioners, and promises a wealth of cutting-edge education, research and the latest vendor technology.

Find all news, video and 360 images posted from ASE 2018.



About 50 percent of patients in cardiogenic shock do not survive, and account for about 90,000 heart attack patients a year who show up in hospital emergency departments. Over the past year there has been a  renewed focus on strategies to reduce cariogenic shock mortality, with presentations on the topic making headlines at the 2017 American College of Cardiology (ACC), 2017 Transcatheter Cardiovascular Therapeutics (TCT) and 2018 Society for Cardiovascular Angiography and Interventions (SCAI) meetings. 


The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon emission computed tomography (SPECT), with a focus on advances in myocardial perfusion imaging (MPI). The 2018 guideline is designed to provide MPI guidelines for conventional and novel SPECT for all nuclear cardiology practitioners.

Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for the Biograph mCT family of positron emission tomography/computed tomography (PET/CT) systems at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). These features, three of which are also available on the Biograph Vision PET/CT scanner, bring advanced clinical capabilities to healthcare providers, enabling them to expand precision medicine and transform the delivery of patient care.

Subscribe Now